Multicenter phase II trial of modified FOLFIRINOX in gemcitabine-refractory pancreatic cancer

Pancreatobiliary Cancer Study Group of Korean Society of Gastrointestinal Cancer

Research output: Contribution to journalArticlepeer-review

9 Citations (Scopus)

Fingerprint Dive into the research topics of 'Multicenter phase II trial of modified FOLFIRINOX in gemcitabine-refractory pancreatic cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences